1-9 of 9
Pall T. Onundarson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Alma R. Oskarsdottir, MD, Brynja R. Gudmundsdottir, MS, Pall T. Onundarson, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1239.
https://doi.org/10.1182/blood-2018-99-116731
Published: 2018
Journal Articles

Thromboembolism and Clinically Relevant Bleeding in Relation to Warfarin Anticoagulation Variability in Patients Monitored with Either Fiix-Prothrombin Time or Quick-Prothrombin Time. the Fiix-Trial

Alma R. Oskarsdottir, BS, Brynja R. Gudmundsdottir, MS, Olafur S. Indridason, MD MPH, Hulda M. Jensdottir, BS, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Brynjar Vidarsson, MD, Charles W. Francis, MD, Pall T. Onundarson, MD
Journal: Blood
Blood (2015) 126 (23): 1129.
https://doi.org/10.1182/blood.V126.23.1129.1129
Published: 2015
Journal Articles

Gender Differences during Long-Term Warfarin Anticoagulation in Patients with Atrial Fibrillation Monitored with Fiix-Prothrombin Time or Prothrombin Time. the Fiix Trial

Hulda M. Jensdottir, BS, Brynjar Vidarsson, MD, Brynja R. Gudmundsdottir, MS, Alma R. Oskarsdottir, BS, Olafur S. Indridason, MD MPH, David O. Arnar, MD PhD, Einar S. Bjornsson, MD PhD, Magnus K. Magnusson, MD, Sigrun H. Lund, PhD, Charles W. Francis, MD, Pall T. Onundarson, MD
Journal: Blood
Blood (2015) 126 (23): 1134.
https://doi.org/10.1182/blood.V126.23.1134.1134
Published: 2015
Journal Articles

INR and Vitamin K Dependent Coagulation Factor Fluctuation during Warfarin Initiation and Stable Therapy in Patients Dosed with the Fiix-Prothrombin Time or the Quick Prothrombin Time. the Fiix Trial

Brynja R. Gudmundsdottir, MS, Petur I. Jonsson, Pall T. Onundarson, MD
Journal: Blood
Blood (2014) 124 (21): 4278.
https://doi.org/10.1182/blood.V124.21.4278.4278
Published: 2014
Journal Articles

Monitoring Warfarin with the Fiix-Prothrombin Time Improves Anticoagulation Stability and Long-Term Clinical Outcome. the Fiix-Trial

Pall T. Onundarson, MD, Charles W. Francis, MD, Einar S. Bjornsson, MDPhD, Magnus K. Magnusson, MD, David O. Arnar, MD, Olafur S. Indridason, MD, Sigrun Helga Lund, PhD, Sigurdur J. Juliusson, BS, Hulda M. Jensdottir, Brynja R. Gudmundsdottir, MS
Journal: Blood
Blood (2014) 124 (21): 347.
https://doi.org/10.1182/blood.V124.21.347.347
Published: 2014
Journal Articles

Critical Role of Factors II and X During Coumarin Anticoagulation and Their Combined Measurement with a New Prothrombin Time Variant (Fiix-PT),

Pall T. Onundarson, MD, Brynja R. Gudmundsdottir, MS, Charles W. Francis, MD
Journal: Blood
Blood (2011) 118 (21): 3354.
https://doi.org/10.1182/blood.V118.21.3354.3354
Published: 2011
Journal Articles

Activated Recombinant Factor VIIa for Intractable Extra-Cranial Hemorrhage in 55 Consecutive Patients

Brynjar Vidarsson, MD, Robert Palmason, MD, Tomas Gudbjartsson, MD PhD, Pall T. Onundarson, MD
Journal: Blood
Blood (2011) 118 (21): 1264.
https://doi.org/10.1182/blood.V118.21.1264.1264
Published: 2011
Journal Articles

Coagulation Induced by Dilute Tissue Factor Depends More Critically on Factor II and X Concentration Than on FVII or FIX

Brynja R. Gudmundsdottir, MSc, Alexia M Bjornsdottir, B.Sc., Pall T. Onundarson, MD
Journal: Blood
Blood (2008) 112 (11): 4084.
https://doi.org/10.1182/blood.V112.11.4084.4084
Published: 2008
Journal Articles

Economy Class Syndrome: A “Pilot” Study.

Sigurdur Y. Kristinsson, MD, Brynjar Vidarsson, MD, Thorvardur J. Love, MD, Vilhjalmur Rafnsson, MD, Jon Hrafnkelsson, MD, Pall T. Onundarson, MD
Journal: Blood
Blood (2005) 106 (11): 4130.
https://doi.org/10.1182/blood.V106.11.4130.4130
Published: 2005